RESULTS	In 123 patients ( per protocol set ) , those remaining free from PAF/PAFL after the treatment were 3.1 % on placebo , 7.7 % on 25 mg/BID , 9.4 % on 50 mg/BID , and 39.4 % on 100 mg/BID of flecainide .\